Although most studies have focused on the role of ApoA1 in atherosclerosis and cardiovascular disease, some studies have revealed relatively lower levels of serum ApoA1 in patients with various cancers, including breast cancer [21–23]. Here, APOA1 is linked to breast carcinoma.